Taiwan Liposome Company News and Activities
Presence
Headquarters: Taiwan
Taiwan Liposome Company is a company listed under the stock ticker 7TLA (TW).
Executives
View the org chart displaying its 16 main executives
Most searched biographies at Taiwan Liposome Company
Create your alert
to follow the executive moves at Taiwan Liposome Company.
Pharmaceuticals
Taiwan Liposome Company has 1,913 competitors including Sanofi (France), Eli Lilly (United States (USA)) and Moderna (United States (USA)).
Popular M&A news in Pharmaceuticals
- Corden Pharma has announced the acquisition of AmbioPharm (posted on June 5 2026).
- Laboratoire Servier has announced the acquisition of Edgewise Therapeutics (posted on June 4 2026).
- Contraline has just announced a $93 Million fundraising (posted on June 3 2026).
Popular contacts in Pharmaceuticals
News
Press releases by Taiwan Liposome Company
- OARSI Presentation Details
- https://www.tlcbio.com/en/news/detail/OARSI2026
- https://www.tlcbio.com/en/news/detail/MarketingApprovalforAmpholipadinChina
- TLC Announces Early Completion of Patient Enrollment in TLC590 Phase II Clinical Trial following Bunionectomy-TLC
- TLC Reports Fiscal Year End 2019 Financial Results and Provides Business Update-TLC
- TLC Announces Dosing of First Patients in Part 2 of TLC590 Phase II Trial for Postsurgical Pain following Bunionectomy-TLC
- TLC to Present at Berenberg Pain Seminar -TLC
- TLC Announces Completion of US$27 Million Financing-TLC
- TLC Reports Third Quarter 2019 Financial Results and Provides Business Update-TLC
- TLC Presents Clinical and Preclinical Data of TLC590 at ANESTHESIOLOGY® Annual Meeting and in International Journal of Nanomedicine-TLC
- View more press releases Close
Social media about Taiwan Liposome Company
- Taiwan Liposome Company on Wikipedia, Google News & Yahoo Finance
- Taiwan Liposome Company on LinkedIn, X (Twitter) & YouTube
